Ciprofloxacin safety in paediatrics: A systematic review

Archives of Disease in Childhood

Volumn 96, Issue 9, 2011, Pages 874-880

  Adefurin, Abiodun ^a   Sammons, Helen ^a   Jacqz Aigrain, Evelyne ^b   Choonara, Imti ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; CIPROFLOXACIN; METHOTREXATE;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ALLERGY; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANXIETY; ARTHRALGIA; ARTHROPATHY; ATAXIA; BIBLIOGRAPHIC DATABASE; BLEEDING; BLOOD CELL COUNT; CINAHL; CONSCIOUSNESS; DIARRHEA; DIZZINESS; DRUG SAFETY; DRUG WITHDRAWAL; EMBASE; EPISTAXIS; EYE DISEASE; FEVER; GROUPS BY AGE; HEADACHE; HEARING IMPAIRMENT; HEART FAILURE; HEMIPARESIS; HOT FLUSH; HUMAN; HYPERREFLEXIA; INJECTION SITE REACTION; INTERSTITIAL NEPHRITIS; INTRACRANIAL HYPERTENSION; IRRITABILITY; JOINT SWELLING; KIDNEY DYSFUNCTION; LEUKOCYTE COUNT; LIMB PAIN; LIVER FUNCTION TEST; MEDLINE; MENTAL DISEASE; MOUTH DISEASE; MUSCLE HYPOTONIA; MUSCULOSKELETAL DISEASE; MYALGIA; NAUSEA AND VOMITING; NERVOUSNESS; OSTEITIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PRURITUS; RASH; RESTLESSNESS; REVIEW; RIGOR; SHIVERING; SIDE EFFECT; SYSTEMATIC REVIEW; TENDON DISEASE; TOXIC MEGACOLON; TREMOR;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; CONTROLLED CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JOINT DISEASES; MALE; MUSCULOSKELETAL DISEASES; PEDIATRICS;

EID: 80051811064     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.208843     Document Type: Review

References (125)

1. Van Bambeke F., Michot J.M., Van Eldere J., et al. Quinolones in 2005: an update. Clin Microbiol Infect 2005;11:256-280 (Pubitemid 40443832)
2. Committee on Infectious Diseases. The use of systemic fluoroquinolones. Pediatrics 2006;118:1287-1292
3. Gendrel D., Chalumeau M., Moulin F., et al. Fluoroquinolones in paediatrics: a risk for the patient or for the community? Lancet Infect Dis 2003;3:537-546 (Pubitemid 37064532)
4. Ingham B., Brentnall D.W., Dale E.A., et al. Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acids. Toxicol Lett 1977;1:21-26 (Pubitemid 8294352)
5. Simonin M.A., Gegout-Pottie P., Minn A., et al. Proteoglycan and collagen biochemical variations during fluoroquinolone-induced chondrotoxicity in mice. Antimicrob Agents Chemother 1999;43:2915-2921
6. Gough A., Barsoum N.J., Mitchell L., et al. Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol Appl Pharmacol 1979;51:177-187 (Pubitemid 10198928)
7. Pfister K., Mazur D., Vormann J., et al. Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats. Antimicrob Agents Chemother 2007;51:1022-1027 (Pubitemid 46355290)
8. Machida M., Kusajima H., Aijima H., et al. Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals. Toxicol Appl Pharmacol 1990;105:403-412 (Pubitemid 20373271)
9. Egerbacher M., Wolfesberger B, Gabler C. In vitro evidence for effects of magnesium supplementation on quinolone-treated horse and dog chondrocytes. Vet Pathol 2001;3 8:143-148 (Pubitemid 32194859)
10. Egerbacher M., Seiberl G., Wolfesberger B., et al. Ciprofloxacin causes cytoskeletal changes and detachment of human and rat chondrocytes in vitro. Arch Toxicol 2000;73:557-563 (Pubitemid 30062487)
11. Ball P. Ciprofloxacin: an overview of adverse experiences. J Antimicrob Chemother 1986;18 (Suppl D): 187-193 (Pubitemid 17214211)
12. Edwards I.R., Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255-1259
13. Saha D., Khan W.A., Karim M.M., et al. Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. Lancet 2005;366:1085-1093 (Pubitemid 41338762)
14. Schaad U.B., Wedgwood J., Ruedeberg A., et al. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis. Pediatr Infect Dis J 1997;16:106-111; discussion 123-6.
15. Chaudhari S., Suryawanshi P., Ambardekar S., et al. Safety profile of ciprofloxacin used for neonatal septicemia. Indian Pediatr 2004;41:1246-1251 (Pubitemid 40101165)
16. Leibovitz E., Janco J., Piglansky L., et al. Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J 2000;19:1060-1067
17. Church D.A., Kanga J.F., Kuhn R.J., et al. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/ tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group. Pediatr Infect Dis J 1997;16:97-105; discussion 123-6.
18. Salam M.A., Dhar U., Khan W.A., et al. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Lancet 1998;352:522-527 (Pubitemid 28372225)
19. Richard D.A., Nousia-Arvanitakis S., Sollich V., et al. Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group. Pediatr Infect Dis J 1997;16:572-578 (Pubitemid 27255757)
20. Zimbabwe, Bangladesh, South Africa (Zimbasa) Dysentery Study Group. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children. Pediatr Infect Dis J 2002;21:1136-1141
21. Aggarwal P., Dutta S., Garg S.K., et al. Multiple dose pharmacokinetics of ciprofloxacin in preterm babies. Indian Pediatr 2004;41:1001-1007 (Pubitemid 39425312)
22. Peltola H., Ukkonen P., Saxén H., et al. Single-dose and steady-state pharmacokinetics of a new oral suspension of ciprofloxacin in children. Pediatrics 1998;101:658-662 (Pubitemid 28180152)
23. Lipman J., Gous A.G., Mathivha L.R., et al. Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough? Intensive Care Med 2002;28:493-500. (Pubitemid 34328036)
24. Rubio T.T., Miles M.V., Lettieri J.T., et al. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation. Pediatr Infect Dis J 1997;16:112-117;discussion 123-6.
25. Redmond A., Sweeney L., MacFarland M., et al. Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning. J Int Med Res 1998;26:304-312 (Pubitemid 29154893)
26. Roland P.S., Kreisler L.S., Reese B., et al. Topical ciprofloxacin/ dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2004;113:e40-e46
27. Roland P.S., Anon J.B., Moe R.D., et al. Topical ciprofloxacin/ dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope 2003;113:2116-2122 (Pubitemid 38063832)
28. Drossou-Agakidou V., Roilides E., Papakyriakidou-Koliouska P., et al. Use of ciprofloxacin in neonatal sepsis: lack of adverse effects up to one year. Pediatr Infect Dis J 2004;23:346-349 (Pubitemid 38508889)
29. Yousef A.A., Fryer C.J., Chedid F.D., et al. A pilot study of prophylactic ciprofloxacin during delayed intensification in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2004;43:637-643 (Pubitemid 39411220)
30. Cuevas L.E., Kazembe P., Mughogho G.K., et al. Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin. J Infect Dis 1995;171:728-731
31. Paganini H., Gómez S., Ruvinsky S., et al. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina. Cancer 2003;97:1775-1780 (Pubitemid 36350721)
32. Doherty C.P., Saha SK, Cutting WA. Typhoid fever, ciprofloxacin and growth in young children. Ann Trop Paediatr 2000;20:297-303.
33. Martell M., de Ben S., Weinberger M., et al. Growth and development in preterm infants receiving fluoroquinolones. J Perinat Med 1996;24:287-291 (Pubitemid 26177369)
34. Schaad U.B., Wedgwood-Krucko J., Guenin K., et al. Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin. Eur J Clin Microbiol Infect Dis 1989;8:858-865 (Pubitemid 19265870)
35. Sen S., Goyal RS, Dev R. Ciprofloxacin in the management of multiple drug resistant typhoid fever. Indian Pediatr 1991;28:417-419
36. Bavdekar A., Chaudhari M., Bhave S., et al. Ciprofloxacin in typhoid fever. Indian J Pediatr 1991;58:335-339
37. Wlazlowski J., Krzyzanska-Oberbek A., Sikora J.P., et al. Use of the quinolones in treatment of severe bacterial infections in premature infants. Acta Pol Pharm 2000;57 (Suppl): 28-31. (Pubitemid 32124636)
38. Naccari F., Salpietro D.C., De Sarro A., et al. Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI). Res Commun Mol Pathol Pharmacol 1998;99:187-192 (Pubitemid 28176053)
39. Orenstein D.M., Pattishall E.N., Noyes B.E., et al. Safety of ciprofloxacin in children with cystic fibrosis. Clin Pediatr (Phila) 1993;32:504-506 (Pubitemid 23249339)
40. Miller M.S., Gaido F., Rourk M.H., Jr, et al. Anaphylactoid reactions to ciprofloxacin in cystic fibrosis patients. Pediatr Infect Dis J 1991;10:164-165
41. Jawad A.S. Cystic fibrosis and drug-induced arthropathy. Br J Rheumatol 1989;28:179-180
42. Lang R., Goshen S., Raas-Rothschild A., et al. Oral ciprofloxacin in the management of chronic suppurative otitis media without cholesteatoma in children: preliminary experience in 21 children. Pediatr Infect Dis J 1992;11:925-929
43. Cheesbrough J.S., Mwema F.I., Green S.D., et al. Quinolones in children with invasive salmonellosis. Lancet 1991;338:127.
44. Dutta P., Rasaily R., Saha M.R., et al. Ciprofloxacin for treatment of severe typhoid fever in children. Antimicrob Agents Chemother 1993;37:1197-1199 (Pubitemid 23141349)
45. Isaacs D., Slack M.P., Wilkinson A.R., et al. Successful treatment of Pseudomonas ventriculitis with ciprofloxacin. J Antimicrob Chemother 1986;17:535-538 (Pubitemid 16143219)
46. Lumbiganon P., Pengsaa K, Sookpranee T. Ciprofloxacin in neonates and its possible adverse effect on the teeth. Pediatr Infect Dis J 1991;10:619-620
47. Karande S.C., Kshirsagar NA. Adverse drug reaction monitoring of ciprofloxacin in pediatric practice. Indian Pediatr 1992;29:181-188
48. Alfaham M., Holt ME, Goodchild MC. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin. Br Med J (Clin Res Ed) 1987;295:699. (Pubitemid 17137936)
49. Ollé-Goig J.E. Multiorgan involvement due to Salmonella typhi: case report. East Afr Med J 2006;83:693-695
50. Toraman Z.A., Yakupogullari Y. Carbapenemase-producing Pseudomonas aeruginosa and ciprofloxcacin use in neonatal intensive care units. J Hosp Infect 2003;54:164-165 (Pubitemid 38002016)
51. Arora R.K., Gupta A., Joshi N.M., et al. Multidrug resistant typhoid fever: study of an outbreak in Calcutta. Indian Pediatr 1992;29:61-66
52. van den Oever H.L., Versteegh F.G., Thewessen E.A., et al. Ciprofloxacin in preterm neonates: case report and review of the literature. Eur J Pediatr 1998;157:843-845 (Pubitemid 28460747)
53. Bannon M.J., Stutchfield P.R., Weindling A.M., et al. Ciprofloxacin in neonatal Enterobacter cloacae septicaemia. Arch Dis Child 1989;64:1388-1391 (Pubitemid 19252713)
54. Lo W.T., Wang C.C., Lee C.M., et al. Successful treatment of multi-resistant Stenotrophomonas maltophilia meningitis with ciprofloxacin in a pre-term infant. Eur J Pediatr 2002;161:680-682
55. Dalle J.H., Auvrignon A., Vassal G., et al. Interaction between methotrexate and ciprofloxacin. J Pediatr Hematol Oncol 2002;24:321-322 (Pubitemid 34506624)
56. Force R.W., Hart M.C., Plummer S.A., et al. Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg 1995;121:880-884
57. Green S.D., Ilunga F., Cheesbrough J.S., et al. The treatment of neonatal meningitis due to gram-negative bacilli with ciprofloxacin: evidence of satisfactory penetration into the cerebrospinal fluid. J Infect 1993;26:253-256 (Pubitemid 23177544)
58. Workman M.R., Price EH, Bullock P. Salmonella meningitis and multiple cerebral abscesses in an infant. Int J Antimicrob Agents 1999;13:131-132 (Pubitemid 29492913)
59. Johansson A., Berglund L., Gothefors L., et al. Ciprofloxacin for treatment of tularemia in children. Pediatr Infect Dis J 2000;19:449-453 (Pubitemid 30307996)
60. Green S., Tillotson G. Use of ciprofloxacin in developing countries. Pediatr Infect Dis J 1997;16:150-159;discussion 160-2.
61. Angel C.A., Green J., Swischuk L., et al. Severe ciprofloxacin-associated pseudomembranous colitis in an eight-year-old child. J Pediatr Surg 2004;39:1590-1592 (Pubitemid 39349753)
62. Black A., Redmond A.O., Steen H.J., et al. Tolerance and safety of ciprofloxacin in paediatric patients. J Antimicrob Chemother 1990;26 (Suppl F): 25-29
63. Gürpinar A.N., Balkan E., Kiliç N., et al. The effects of a fluoroquinolone on the growth and development of infants. J Int Med Res 1997;25:302-306 (Pubitemid 27472759)
64. Schaad U.B., Sander E., Wedgwood J., et al. Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients. Pediatr Infect Dis J 1992;11:1047-1049
65. Schaad U.B., Stoupis C., Wedgwood J., et al. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr Infect Dis J 1991;10:723-729
66. Mullen C.A., Petropoulos D., Rytting M., et al. Acute reversible arthropathy in a pediatric patient with cancer treated with a short course of ciprofloxacin for febrile neutropenia. J Pediatr Hematol Oncol 1998;20:516-517 (Pubitemid 29133215)
67. Pradhan K.M., Arora N.K., Jena A., et al. Safety of ciprofloxacin therapy in children: magnetic resonance images, body fluid levels of fluoride and linear growth. Acta Paediatr 1995;84:555-560
68. Chyský V., Kapila K., Hullmann R., et al. Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection 1991;19:289-296
69. Bendig J.W., Kyle P.W., Giangrande P.L., et al. Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin. J R Soc Med 1987;80:316-317 (Pubitemid 17119476)
70. Park J.R., Coughlin J., Hawkins D., et al. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients. Med Pediatr Oncol 2003;40:93-98 (Pubitemid 35471372)
71. Sarkar S., Singh M, Narang A. Successful treatment of hospital acquired Klebsiella pneumoniae meningitis in a neonate with ciprofloxacin. Indian Pediatr 1993;30:913-914 (Pubitemid 23245377)
72. Singh U.K., Sinha R.K., Prasad B., et al. Ciprofloxacin in children: is arthropathy a limitation? Indian J Pediatr 2000;67:386-387 (Pubitemid 30418046)
73. Karande S., Kshirsagar NA. Ciprofloxacin use: acute arthropathy and long-term follow up. Indian Pediatr 1996;33:910-916
74. Hampel B., Hullmann R, Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use-safety report. Pediatr Infect Dis J 1997;16:127-129;discussion 160-2.
75. Bethell D.B., Hien T.T., Phi L.T., et al. Effects on growth of single short courses of fluoroquinolones. Arch Dis Child 1996;74:44-46 (Pubitemid 26042694)
76. Dohar J., Giles W., Roland P., et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2006;118:e561-e569 (Pubitemid 46089982)
77. Jick S Ciprofloxacin safety in a pediatric population Pediatr Infect Dis J 1997;16:130-3; discussion 133-4, 160-2.
78. Thomsen L.L., Paerregaard A. Treatment with ciprofloxacin in children with typhoid fever. Scand J Infect Dis 1998;30:355-357 (Pubitemid 28488221)
79. Danisovicová A., Brezina M., Belan S., et al. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey. Chemotherapy 1994;40:209-214 (Pubitemid 24078024)
80. Belet N., Haciömeroglu P, Küçüködük S. Ciprofloxacin treatment in newborns with multi-drug-resistant nosocomial Pseudomonas infections. Biol Neonate 2004;85:263-268 (Pubitemid 38813001)
81. Green S.D., Ilunga F.M., Numbi A., et al. An open study of ciprofloxacin for the treatment of proven or suspected extra-intestinal salmonellosis in African children: a preliminary report. Adv Antimicrob Antineoplas Chemo 1992;11 (Suppl): 181-187
82. Goshen S., Raas-Rothschild A, Lang R. Oral ciprofloxacin in the management of children with chronic suppurative otitis media without cholesteatoma. Adv Antimicrob Antineoplas Chemo 1992;11 (Suppl): 175-177
83. Kuhn R., Palmejar A, Kanga J. Tolerability of ciprofloxacin in pediatric patients with cystic fibrosis. Adv Antimicrob Antineoplas Chemo 1992;11 (Suppl): 269-271
84. Rubio T.T. Clinical and laboratory experience with ciprofloxacin in children two to sixteen years of age. Adv Antimicrob Antineoplas Chemo 1992;11(Suppl):151-154
85. Chotigeat U., Khorana M, Waranawat N. Successful treatment of late onset infection due to multi-drug resistant Acinetobacter Lwoffii in a low birth weight neonate using ciprofloxacin. J Med Assoc Thai 2001;84:910-913
86. Khaneja M., Naprawa J., Kumar A., et al. Successful treatment of late-onset infection due to resistant Klebsiella pneumoniae in an extremely low birth weight infant using ciprofloxacin. J Perinatol 1999;19:311-314
87. Khan D.M., Bhutta ZA. Ciprofloxacin in multi-resistant infections in childhood: an audit. J Pak Med Assoc 1995;45:147-150
88. Uppal R., Jhaj R, Malhotra S. Adverse drug reactions to fluoroquinolones at a tertiary care hospital in northern India. J Assoc Physicians India 1998;46:946-947 (Pubitemid 128524024)
89. Wintermeyer S.M., Hart MC, Nahata MC. Efficacy of ototopical ciprofloxacin in pediatric patients with otorrhea. Otolaryngol Head Neck Surg 1997;116:450-453 (Pubitemid 27203988)
90. Hussey G., Kibel M, Parker N. Ciprofloxacin treatment of multiply drug-resistant extrapulmonary tuberculosis in a child. Pediatr Infect Dis J 1992;11:408-409
91. Dab I., Desmyttere S, Malfroot A. Repeated use of ciprofloxacin in a pediatric cyctic fibrosis population. Adv Antimicrob Antineoplas Chemo 1992;11 (Suppl): 143-146
92. Pillay T., Pillay D.G., Adhikari M., et al. An outbreak of neonatal infection with Acinetobacter linked to contaminated suction catheters. J Hosp Infect 1999;43:299-304. (Pubitemid 30045829)
93. Hacimustafaoglu M., Cil E, Nacarküçük E. Unusual adverse effects of ciprofloxacin: purpuric eruptions and local venospasm. Pediatr Infect Dis J 1995;14:551-552
94. Brown N.M., Körner R.J., Zollman C.E., et al. Ciprofloxacin treatment of bacterial endocarditis involving prosthetic material after cardiac surgery. Arch Dis Child 1997;76:68-69 (Pubitemid 27060498)
95. Rfidah E.I., Findlay CA, Beattie TJ. Reversible encephalopathy after intravenous ciprofloxacin therapy. Pediatr Nephrol 1995;9:250-251
96. Abouesh A., Stone C, Hobbs WR. Antimicrobial-induced mania (antibiomania): a review of spontaneous reports. J Clin Psychopharmacol 2002;22:71-81. (Pubitemid 34103001)
97. Trautmann M., Held T., Ruhnke M., et al. A case of rhinoscleroma cured with ciprofloxacin. Infection 1993;21:403-406
98. Lotti T., Mirone V., Imbimbo C., et al. Ciprofloxacin in the treatment of urinary tract infections. J Int Med Res 1987;15:240-244 (Pubitemid 17133927)
99. Simpson J., Watson A.R., Mellersh A., et al. Typhoid fever, ciprofloxacin, and renal failure. Arch Dis Child 1991;66:1083-1084
100. Davis H., McGoodwin E, Reed TG. Anaphylactoid reactions reported after treatment with ciprofloxacin. Ann Intern Med 1989;111:1041-1043
101. Chalumeau M., Tonnelier S., D'Athis P., et al.; Pediatric Fluoroquinolone Safety Study Investigators. Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics 2003;111:e714-e719
102. Winrow A.P., Supramaniam G. Benign intracranial hypertension after ciprofloxacin administration. Arch Dis Child 1990;65:1165-1166 (Pubitemid 20330973)
103. Yee C.L., Duffy C., Gerbino P.G., et al. Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. Pediatr Infect Dis J 2002;2 1:525-529 (Pubitemid 34625833)
104. Hoppe J.E., Dopfer R., Huber S., et al. Eradication of Salmonella dublin in an immunodeficient child by combined use of ceftriaxone and ciprofloxacin after failure of either agent alone. Infection 1989;17:399-400. (Pubitemid 20013471)
105. Valerius N.H., Koch C, Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991;338:725-726
106. Gbadoé A.D., Dogba A., Dagnra A.Y., et al. [Acute osteomyelitis in the child with sickle cell disease in a tropical zone: value of oral fluoroquinolones]. Arch Pediatr 2001;8:1305-1310
107. Mishra A., Mishra S., Jaganath G., et al. Acinetobacter sepsis in newborns. Indian Pediatr 1998;35:27-32. (Pubitemid 128518198)
108. Milio M.C., Campana S. [Use of quinolones in the treatment of Pseudomonas aeruginosa infections in children with cystic fibrosis]. Pediatr Med Chir 1995;17:53-55
109. Ahmed A.S., Khan N.Z., Saha S.K., et al. Ciprofloxacin treatment in preterm neonates in Bangladesh: lack of effects on growth and development. Pediatr Infect Dis J 2006;25:1137-1141 (Pubitemid 44900677)
110. Hata A., Honda Y., Asada K., et al. Mycoplasma hominis meningitis in a neonate: case report and review. J Infect 2008;57:338-343
111. Ghosh G, Chakraborty S, Ray J, et al Parenteral ciprofloxacin in persistent diarrhoea in children. J Indian Med Assoc 1995;93:382, 384.
112. Gross R.D., Hoffman RO, Lindsay RN. A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children. Clin Pediatr (Phila) 1997;36:435-444 (Pubitemid 27344149)
113. Nejjari N., Benomar S, Lahbabi MS. [Nosocomial infections in neonatal and pediatric intensive care. The appeal of ciprofloxacin]. Arch Pediatr 2000;7:1268-1273
114. Dey S.K. Nightmare due to ciprofloxacin in young patients. Indian Pediatr 1995;32:918-920
115. Odoul F., Le Guellec C., Giraut C., et al. Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses. Therapie 2001;56:519-524 (Pubitemid 34027024)
116. Dutta S., Chowdhary G., Kumar P., et al. Ciprofloxacin administration to very low birth weight babies has no effect on linear growth in infancy. J Trop Pediatr 2006;52:103-106
117. Bhutta Z.A., Farooqui BJ, Sturm AW. Eradication of a multiple drug resistant Salmonella paratyphi A causing meningitis with ciprofloxacin. J Infect 1992;25:215-219
118. Sendzik J., Lode H, Stahlmann R. Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data. Int J Antimicrob Agents 2009;33:194-200.
119. Medrano San Ildefonso M., Mauri Llerda JA, Bruscas Izu C. [Fluoroquinolone-induced tendon diseases]. An Med Interna 2007;24:227-230
120. Maurin N. [Fluoroquinolone-induced Achilles tendon rupture]. Dtsch Med Wochenschr 2008;133:241-244
121. Levadoux M., Carli P., Gadea J.F., et al. [Repeated rupture of the extensor tendons of the hand due to fluoroquinolones. Apropos of a case]. Ann Chir Main Memb Super 1997;16:130-133
122. van der Linden P.D., van Puijenbroek E.P., Feenstra J., et al. Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum 2001;45:235-239 (Pubitemid 32952902)
123. Menschik M., Neumüller J., Steiner C.W., et al. Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro. Antimicrob Agents Chemother 1997;41:2562-2565 (Pubitemid 27467576)
124. von Keutz E., Rühl-Fehlert C., Drommer W., et al. Effects of ciprofloxacin on joint cartilage in immature dogs immediately after dosing and after a 5-month treatment-free period. Arch Toxicol 2004;78:418-424 (Pubitemid 39062235)
125. Mohanasundaram J., Mohanasundaram S. Effect of duration of treatment on ciprofloxacin induced arthropathy in young rats. Indian J Pharmacol 2001;33:100-103 (Pubitemid 32435518)